https://scholars.lib.ntu.edu.tw/handle/123456789/620206
Title: | First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma | Authors: | Italiano A. Cassier P.A. CHIA-CHI LIN Alanko T. Peltola K.J. Gazzah A. Shiah H.-S. Calvo E. Cervantes A. Roda D. Tosi D. Gao B. Millward M. Warburton L. Tanner M. Englert S. Lambert S. Parikh A. Afar D.E. Vosganian G. Moreno V. |
Issue Date: | 2022 | Publisher: | Springer Science and Business Media Deutschland GmbH | Journal Volume: | 71 | Journal Issue: | 2 | Start page/Pages: | 417-431 | Source: | Cancer Immunology, Immunotherapy | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85109344549&doi=10.1007%2fs00262-021-02973-w&partnerID=40&md5=1460756dafddfaa1e2f33275c4f3423b https://scholars.lib.ntu.edu.tw/handle/123456789/620206 |
ISSN: | 0340-7004 | DOI: | 10.1007/s00262-021-02973-w |
Appears in Collections: | 臨床醫學研究所 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.